Challenging the validity of the EPO index

American Journal of Kidney Diseases

Volumn 47, Issue 1, 2006, Pages 166.e1-166.e13

  Kaysen, George A ^a   Müller, Hans G ^b   Ding, Jimin ^b   Chertow, Glenn M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Anemia; End stage renal disease (ESRD); Hemodialysis (HD); Inflammation; Iron; Mortality

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOLLOW UP; HEALTH HAZARD; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL; TIME; UNITED STATES; VALIDATION PROCESS;

EID: 29244487098     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.09.013     Document Type: Article

References (54)

1. R.L. Pisoni, J.L. Bragg-Gresham, E.W. Young Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 2004 94 111
2. F. Locatelli, F. Conte, D. Marcelli The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - The experience of the Lombardy Dialysis Registry Nephrol Dial Transplant 13 1998 1642 1644
3. F. Locatelli, R.L. Pisoni, C. Combe Anaemia in haemodialysis patients in five European countries Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 2004 121 132
4. A. Besarab, W.K. Bolton, J.K. Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 1998 584 590
5. H. Furuland, T. Linde, J. Ahlmen, A. Christensson, U. Strombom, B.G. Danielson A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients Nephrol Dial Transplant 18 2003 353 361
6. D.J. Cotter, K. Stefanik, Y. Zhang, M. Thamer Improved survival with higher hematocrits Where is the evidence? Semin Dial 17 2004 181 183
7. P.M. Ridker, J.E. Buring, J. Shih Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
8. J.Y. Yeun, R.A. Levine, V. Mantadilok, G.A. Kaysen C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 35 2000 469 476
9. P. Stenvinkel The role of inflammation in the anaemia of end-stage renal disease Nephrol Dial Transplant 16 suppl 7 2001 S36 S40
10. G. Nicolas, C. Chauvet, L. Viatte The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation J Clin Invest 110 2002 1037 1044
11. E. Nemeth, S. Rivera, V. Gabayan IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 2004 1271 1276
12. M. Neidhart, P. Bruhlmann, S. Gay, B.A. Michel Activation of CD4+ and CD8+ T-lymphocytes in bone marrow associated with reduced erythropoiesis in patients with chronic inflammation and anaemia Schweiz Med Wochenschr 128 1998 1618 1623
13. A.C. Cooper, A. Mikhail, M.W. Lethbridge, D.M. Kemeny, I.C. Macdougall Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy J Am Soc Nephrol 14 2003 1776 1784
14. I.C. Macdougall, A.C. Cooper Erythropoietin resistance The role of inflammation and pro-inflammatory cytokines Nephrol Dial Transplant 17 suppl 11 2002 S39 S43
15. J. Gunnell, J.Y. Yeun, T.A. Depner, G.A. Kaysen Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients Am J Kidney Dis 33 1999 63 72
16. P. Barany, J.C. Divino Filho, J. Bergstrom High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients Am J Kidney Dis 29 1997 565 568
17. K. Kalantar-Zadeh, C.J. McAllister, R.S. Lehn, G.H. Lee, A.R. Nissenson, J.D. Kopple Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients Am J Kidney Dis 42 2003 761 773
18. G.A. Kaysen, J.A. Dubin, H.G. Muller, L.M. Rosales, N.W. Levin The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group Kidney Int 58 2000 346 352
19. G. Tutz, G. Kauermann Generalized linear random effects models with varying coefficients Comput Stat Data Anal 43 2003 13 28
20. Z. Cai, Y. Sun Local linear estimation for time-dependent coefficients in Cox regression models Scand J Stat 30 2003 93 111
21. H.G. Müller, K. Prewitt Multiparameter bandwidth processes and adaptive surface smoothing J Multivariate Anal 47 1993 1 21
22. D. Brancaccio, M. Cozzolino, M. Gallieni Hyperparathyroidism and anemia in uremic subjects A combined therapeutic approach J Am Soc Nephrol 15 suppl 1 2004 S21 S24
23. J.Z. Ma, J. Ebben, H. Xia, A.J. Collins Hematocrit level and associated mortality in hemodialysis patients J Am Soc Nephrol 10 1999 610 619
24. F. Locatelli, F. Conte, D. Marcelli The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - The experience of the Lombardy Dialysis Registry Nephrol Dial Transplant 13 1998 1642 1644
25. H. Xia, J. Ebben, J.Z. Ma, A.J. Collins Hematocrit levels and hospitalization risks in hemodialysis patients J Am Soc Nephrol 10 1999 1309 1316
26. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, P.E. Barre The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 31 1998 53 61
27. A. Levin, C.R. Thompson, J. Ethier Left ventricular mass index increase in early renal disease Impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
28. N. Ofsthun, J. Labrecque, E. Lacson, M. Keen, J.M. Lazarus The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients Kidney Int 63 2003 1908 1914
29. S. Li, R.N. Foley, A.J. Collins Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States Kidney Int 65 2004 1864 1869
30. S. Li, A.J. Collins Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients Kidney Int 65 2004 626 633
31. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
32. B.A. Warady, M. Ho Morbidity and mortality in children with anemia at initiation of dialysis Pediatr Nephrol 18 2003 1055 1062
33. D.S. Silverberg, D. Wexler, A. Iaina The importance of anemia and its correction in the management of severe congestive heart failure Eur J Heart Fail 4 2002 681 686
34. D.S. Silverberg, D. Wexler, M. Blum The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol Dial Transplant 18 2003 141 146
35. J.W. Eschbach, M.R. Kelly, N.R. Haley, R.I. Abels, J.W. Adamson Treatment of the anemia of progressive renal failure with recombinant human erythropoietin N Engl J Med 321 1989 158 163
36. J.W. Eschbach, J.C. Egrie, M.R. Downing, J.K. Browne, J.W. Adamson Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 1987 73 78
37. D.E. Uehlinger, F.A. Gotch, L.B. Sheiner A pharmacodynamic model of erythropoietin therapy for uremic anemia Clin Pharmacol Ther 51 1992 76 89
38. S.A. Lipton Erythropoietin for neurologic protection and diabetic neuropathy N Engl J Med 350 2004 2516 2517
39. R. Bianchi, B. Buyukakilli, M. Brines Erythropoietin both protects from and reverses experimental diabetic neuropathy Proc Natl Acad Sci U S A 101 2004 823 828
40. P. Villa, P. Bigini, T. Mennini Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis J Exp Med 198 2003 971 975
41. M. Leist, P. Ghezzi, G. Grasso Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 242
42. Y.H. Chung, K.M. Joo, Y.J. Lee, W.B. Lee, K.H. Lee, C.I. Cha Enhanced expression of erythropoietin in the central nervous system of SOD1(G93A) transgenic mice Brain Res 1016 2004 272 280
43. A.F. Tramontano, R. Muniyappa, A.D. Black Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem Biophys Res Commun 308 2003 990 994
44. C. Moon, M. Krawczyk, D. Ahn Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc Natl Acad Sci U S A 100 2003 11612 11617
45. M. Koc, A. Bihorac, M.S. Segal Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients Am J Kidney Dis 42 2003 704 712
46. F.H. Bahlmann, K. De Groot, J.M. Spandau Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
47. K. de Groot, F.H. Bahlmann, J. Sowa Uremia causes endothelial progenitor cell deficiency Kidney Int 66 2004 641 646
48. T. Eizawa, Y. Murakami, K. Matsui Circulating endothelial progenitor cells are reduced in hemodialysis patients Curr Med Res Opin 19 2003 627 633
49. T. Drueke, V. Witko-Sarsat, Z. Massy Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease Circulation 106 2002 2212 2217
50. R.D. Klausner, T.A. Rouault, J.B. Harford Regulating the fate of mRNA The control of cellular iron metabolism Cell 72 1993 19 28
51. H.L. Bonkovsky, B.F. Banner, A.L. Rothman Iron and chronic viral hepatitis Hepatology 25 1997 759 768
52. A.J. Collins, S. Li, J.Z. Ma, C. Herzog Cardiovascular disease in end-stage renal disease patients Am J Kidney Dis 38 suppl 1 2001 S26 S29
53. A. Besarab Iron and cardiac disease in the end-stage renal disease setting Am J Kidney Dis 34 suppl 2 1999 S18 S24
54. M. Facer, H.G. Müller Nonparametric estimation of the peak location in a response surface J Multivariate Anal 87 2003 191 217